Cytomos Overview
- Year Founded
-
2011

- Status
-
Private
- Employees
-
31

- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$7.79M
- Investors
-
5
Cytomos General Information
Description
Developer of a dielectric spectroscopy technology designed to assist with label-free cell analysis for biomedical research. The company's patented cell analysis technology ensures that every cell is analyzed providing granular information on individual cells and the whole sample population, facilitates automated and quantitative sample assessment, phenotypic drug discovery, and stem cell therapy, enabling medical researchers to find functional endpoints that generate content fingerprints to prepare the right dose thereby making cell-based diagnostics efficient.
Contact Information
Website
www.cytomos.comCorporate Office
- 1st Floor, Charles Darwin House
- Milton Bridge, The Edinburgh Technopole
- Edinburgh EH26 0PY
- Scotland, United Kingdom
Corporate Office
- 1st Floor, Charles Darwin House
- Milton Bridge, The Edinburgh Technopole
- Edinburgh EH26 0PY
- Scotland, United Kingdom
Cytomos Timeline
Cytomos Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Later Stage VC | 29-Oct-2024 | $7.79M | Completed | Generating Revenue | ||
7. Grant | 01-Dec-2022 | Completed | Generating Revenue | |||
6. Seed Round | 28-Jun-2022 | Completed | Generating Revenue | |||
5. Seed Round | 24-May-2021 | Completed | Startup | |||
4. Seed Round | 26-Jun-2020 | Completed | Startup | |||
3. Seed Round | 23-Apr-2018 | Completed | Startup | |||
2. Seed Round | 01-Mar-2016 | $768K | $925K | Completed | Startup | |
1. Seed Round | 15-Dec-2014 | $157K | $157K | Completed | Startup |
Cytomos Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | 35,295 | $0.000013 | $8.91 | $8.91 | 1x | $8.91 | 2.39% | |
Ordinary | 126,050 | $0.000013 | $6.63 | $6.63 | 1x | $6.63 | 8.55% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cytomos Patents
Cytomos Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-202414700-D0 | Cell analysis | Pending | 07-Oct-2024 | ||
GB-202413794-D0 | Cell analysis | Pending | 19-Sep-2024 | ||
GB-202318310-D0 | Cell selection | Pending | 30-Nov-2023 | ||
GB-202411710-D0 | Cell selection | Inactive | 30-Nov-2023 | ||
GB-2636141-A | Cell selection | Pending | 30-Nov-2023 | G01N15/1023 |
Cytomos Signals
Cytomos Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
British Business Bank | Lender/Debt Provider | Minority | ||
Innovate UK | Government | |||
Old College Capital | Corporate Venture Capital | Minority | ||
Scottish Enterprise | Government | Minority | ||
Archangel Investors | Angel Group | Minority |
Cytomos FAQs
-
When was Cytomos founded?
Cytomos was founded in 2011.
-
Where is Cytomos headquartered?
Cytomos is headquartered in Edinburgh, United Kingdom.
-
What is the size of Cytomos?
Cytomos has 31 total employees.
-
What industry is Cytomos in?
Cytomos’s primary industry is Biotechnology.
-
Is Cytomos a private or public company?
Cytomos is a Private company.
-
What is the current valuation of Cytomos?
The current valuation of Cytomos is
. -
What is Cytomos’s current revenue?
The current revenue for Cytomos is
. -
How much funding has Cytomos raised over time?
Cytomos has raised $15.4M.
-
Who are Cytomos’s investors?
British Business Bank, Innovate UK, Old College Capital, Scottish Enterprise, and Archangel Investors have invested in Cytomos.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »